North America Drug Delivery Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Mar 2020
  • North America
  • 254 Pages
  • No of Tables: 183
  • No of Figures: 31

North America Drug Delivery Market, By Product Type (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Opthalmic Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery), End User (Hospitals, Community Healthcare, Home Healthcare, Clinics, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Direct Tenders, Online Pharmacy), Country ( U.S. Mexico, Canada), Market Trends and Forecast to 2027

North America Drug Delivery Market

Market Analysis and Insights: North America Drug Delivery Market

Drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.4% in the forecast period of 2020 to 2027 and is expected to reach USD 1,005.93 billion by 2027. Rising acceptance of self-administering drugs and increasing awareness about diagnosis and treatment around the globe is a driving factor for the market growth.

The process of introducing a therapeutic effect in the body of human by administering a drug at a specific targeted site is known as drug delivery. By controlling the rate, time and release of drug in the body the safety and efficacy of drug can be improved. There can be many ways of delivering drugs like, oral, injectable, pulmonary, nasal and others. The drug delivery systems are made advanced by studying and exploiting the properties of nanoparticles, which have made the process of drug delivery more efficient and time saving.

Drug delivery market has increased with technological development and the growth in the development of biologics in the developed as well as developing countries. For instance, for the manufacturing of large scale mono clonal antibodies, pharmaceutical companies like Sanofi and Lonza are planning to invest USD 299.43 million by the year 2022.

Rising prevalence of chronic and non-chronic disease has increased the market for drug delivery devices as the numbers of people that are being treated are more and also the latest technological development has led to the treatment of very rare and impossible to treat diseases, therefore more people will be attracted towards them. Currently, various research studies are taking place which is anticipated to create a competitive advantage for manufacturers to create novel and inventive drug delivery devices and expected to offer various other opportunities in the drug delivery market. However, high cost of drug delivery procedures and rigid regulations for drug delivery procedures is estimated to restraint the market growth as to get approvals is difficult and a problematic task along with the enforced monetary liability upon drug delivery devices manufacturers and researchers.

This Drug Delivery Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Drug Delivery Market

North America Drug Delivery Market Scope and Market Size

Drug delivery market is segmented on the basis of product type, end user, and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, opthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery. In 2020, oral drug delivery segment is expected to dominate the market due to the high reception of oral drug delivery route of administration by the patients as it is one of the humblest, convenient, and harmless routes for drug administration.
  • On the basis of end user, the market is segmented into hospitals, community healthcare, home healthcare, clinics and others. In 2020, hospitals segment is expected to dominate the market as hospitals are the first contact points for various types of treatments and surgical procedures, also the needs of all the in-house patients are catered.
  • On the basis of distribution channel, the market is segmented into hospital pharmacies, pharmacy stores, direct tenders and online pharmacy. In 2020, direct tenders segment is expected to dominate the market as cost benefits are provided to end users by direct tenders as compared to retail sales as well as direct tenders right away supply drug delivery devices from manufacturer to hospitals, dermatological clinics and others.

Drug Delivery Market Country Level Analysis

Drug delivery market is analysed and market size information is provided by country, product type, end user, and distribution channel as referenced above.

The countries covered in drug delivery market report are the U.S., Canada and Mexico in North America. The U.S. is dominating in the North America region because of the increase in the adoption rate of new technological advancements in the drug delivery.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Fractional Drug Delivery

Drug delivery market report also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in Drug delivery and changes in regulatory scenarios with their support for the Drug delivery market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Drug Delivery Market Share Analysis

Drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to North America drug delivery market.

The major players covered in the report are Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, Antares Pharma, GlaxoSmithKline Plc, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Nemera and Sanofi among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of Drug delivery market.

For instance,

  • In February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson Services, Inc. told about the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) of DARZALEX along with Kyprolis and dexamethasone which is used to treat relapsed/refractory multiple myeloma.
  • In January 2020, Novartis AG declared the complete acquisition of The Medicines Company, which gives it an opportunity to include an investigational first in class cholesterol lowering therapy, inclisiran which will open many options for this organization.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for Drug delivery through expanded range of size.

Customization Available : North America Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016

TABLE 2 MOST EXPENSIVE DRUGS IN THE U.S.

TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2019-2020

TABLE 4 LIST OF FDA APPROVED GENERICS, IN 2019

TABLE 5 PATENT EXPIRY OF DRUGS, 2019

TABLE 6 NORTH AMERICA DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2018-2027 (USD BILLION)

TABLE 7 NORTH AMERICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 8 NORTH AMERICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 9 NORTH AMERICA SOLID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 10 NORTH AMERICA LIQUID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 11 NORTH AMERICA SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 12 NORTH AMERICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 13 NORTH AMERICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 14 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 15 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 16 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 17 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 18 NORTH AMERICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 19 NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 20 NORTH AMERICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 21 NORTH AMERICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 22 NORTH AMERICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 23 NORTH AMERICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 24 NORTH AMERICA SEMI SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 25 NORTH AMERICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 26 NORTH AMERICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 27 NORTH AMERICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 28 NORTH AMERICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 29 NORTH AMERICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 30 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 31 NORTH AMERICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 32 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 33 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 34 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 35 NORTH AMERICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 36 NORTH AMERICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 37 NORTH AMERICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 38 NORTH AMERICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 39 NORTH AMERICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 40 NORTH AMERICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 41 NORTH AMERICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 42 NORTH AMERICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 43 NORTH AMERICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 44 NORTH AMERICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 45 NORTH AMERICA HOPITALS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 46 NORTH AMERICA HOME HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 47 NORTH AMERICA CLINICS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 48 NORTH AMERICA COMMUNITY HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 49 NORTH AMERICA OTHERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 50 NORTH AMERICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 51 NORTH AMERICA DIRECT TENDERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 52 NORTH AMERICA HOSPITAL PHARMACIES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 53 NORTH AMERICA PHARMACY STORES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 54 NORTH AMERICA ONLINE PHARMACY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 55 NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, 2020-2027 (USD BILLION)

TABLE 56 NORTH AMERICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 57 NORTH AMERICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 58 NORTH AMERICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 59 NORTH AMERICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 60 NORTH AMERICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 61 NORTH AMERICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 62 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 63 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 64 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 65 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 66 NORTH AMERICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 67 NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 68 NORTH AMERICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 69 NORTH AMERICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 70 NORTH AMERICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 71 NORTH AMERICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 72 NORTH AMERICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 73 NORTH AMERICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 74 NORTH AMERICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 75 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 76 NORTH AMERICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 77 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 78 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 79 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 80 NORTH AMERICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 81 NORTH AMERICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 82 NORTH AMERICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 83 NORTH AMERICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 84 NORTH AMERICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 85 NORTH AMERICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 86 NORTH AMERICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 87 NORTH AMERICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 88 U.S. DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 89 U.S. ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 90 U.S. SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 91 U.S. LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 92 U.S. SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 93 U.S. INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 94 U.S. INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 95 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 96 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 97 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 98 U.S. SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 99 U.S. INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 100 U.S. OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 101 U.S. OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 102 U.S. OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 103 U.S. LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 104 U.S. SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 105 U.S. NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 106 U.S. TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 107 U.S. TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 108 U.S. TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 109 U.S. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 110 U.S. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 111 U.S. SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 112 U.S. IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 113 U.S. TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 114 U.S. ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 115 U.S. OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 116 U.S. PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 117 U.S. NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 118 U.S. DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 119 U.S. DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 120 CANADA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 121 CANADA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 122 CANADA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 123 CANADA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 124 CANADA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 125 CANADA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 126 CANADA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 127 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 128 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 129 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 130 CANADA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 131 CANADA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 132 CANADA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 133 CANADA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 134 CANADA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 135 CANADA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 136 CANADA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 137 CANADA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 138 CANADA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 139 CANADA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 140 CANADA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 141 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 142 CANADA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 143 CANADA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 144 CANADA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 145 CANADA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 146 CANADA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 147 CANADA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 148 CANADA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 149 CANADA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 150 CANADA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 151 CANADA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 152 MEXICO DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 153 MEXICO ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 154 MEXICO SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 155 MEXICO LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 156 MEXICO SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 157 MEXICO INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 158 MEXICO INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 159 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 160 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 161 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 162 MEXICO SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 163 MEXICO INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 164 MEXICO OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 165 MEXICO OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 166 MEXICO OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 167 MEXICO LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 168 MEXICO SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 169 MEXICO NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 170 MEXICO TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 171 MEXICO TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 172 MEXICO TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 173 MEXICO SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 174 MEXICO LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 175 MEXICO SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 176 MEXICO IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 177 MEXICO TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 178 MEXICO ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 179 MEXICO OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 180 MEXICO PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 181 MEXICO NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 182 MEXICO DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 183 MEXICO DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

Browse Related Reports

Global Injectable Drug Delivery Market - Industry Trends and Forecast to 2025

North America Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

Europe Drug Delivery Market – Industry Trends and Forecast to 2027

Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

Europe Topical Drug Delivery Market – Industry Trends and Forecast to 2027

North America Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Trends and Forecast to 2027

Global Implantable Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary Drug Delivery Market - Industry Trends and Forecast to 2027

Global Oral Drug Delivery Market – Industry Trends and Forecast to 2027

Global Pulmonary/Respiratory Drug Delivery Market – Industry Trends and Forecast to 2027

Global Nasal Drug Delivery Market – Industry Trends and Forecast to 2027

Global Needle-Free Drug Delivery Market – Industry Trends - Forecast to 2026

Global Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Asia-Pacific Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Europe Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Middle East - Africa Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

North America Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2026

Global Inflammatory Disease Drug Delivery Market – Industry Trends & Forecast to 2026

Global Buccal Drug Delivery Market - Industry Trends and Forecast to 2026

U.S. Rx Dermatology Topical Drug Delivery Market – Industry Trends and Forecast to 2027

Global Drug Delivery Market – Industry Trends and Forecast to 2027

Asia-Pacific Drug Delivery Market – Industry Trends and Forecast to 2027

Middle East and Africa Drug Delivery Market – Industry Trends and Forecast to 2027

Global Liposome Drug Delivery Market - Industry Trends and Forecast to 2027


Browse Related Blogs

Global Injectable drug delivery market is poised to reach USD 797.2 billion by 2022

Global Topical Drug Delivery Market is Expected to Reach an Estimated Value of USD 240.76 billion by 2026

North America Drug Delivery Market is poised to grow at 6.4% till 2024

Europe Drug Delivery Market is poised to grow at 7.3% from 2017 to 2024

Topical Drug Delivery Market to Grow at a CAGR of 9% in the Forecast Period of 2019 to 2026

Injectable Drug Delivery Market Rising at 12.4% CAGR Due to Surging Prevalence of Chronic Diseases

North America Injectable Drug Delivery Market is Poised to Grow at 11.0% to 2024

Asia-Pacific (APAC) Injectable Drug Delivery Market is Poised to Grow at 12.4% To 2024

Europe Injectable Drug Delivery Market Poised to Grow At 11.9% till 2024

Global Injectable Drug Delivery Market is Expected to Grow by CAGR 11.5% In The Forecast Period 2017 To 2024

North America Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

North America Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2017-2024

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Global Injectable Drug Delivery Market is Growing at a Significant Rate in the Forecast Period 2018-2025

Nasal Drug Delivery Market to Witness High Demand Due to Rising Respiratory Problems

Increasing Prevalence of Skin Disease or Condition, Rising Aging Population, Growth in Topical Drug Delivery, Increasing Research and Development of New Dermatological Drugs are Expected to Drive the Global Rx Dermatology Topical Drug Delivery Market in the forecast period of 2019-2026

Oral Drug Delivery Market 2019: Size, Share, Scope, Growth Opportunities Analysis By AbbVie, Inc., Amgen, Inc., Catalent Inc, Kemwell Bipharma., Pfizer, Inc., Novartis AG, Biocon, Sanofi, Novo Nordisk A/S. Johnson & Johnson Services, Inc. And Others

U.S. Rx Dermatology Topical Drug Delivery Market is Expected to grow at 4.9% in the Forecast Period of 2020 to 2027

Global Drug Delivery Market is Expected to grow at 8.0% in the Forecast Period of 2020 to 2027

Global Implantable Drug Delivery Market is Rising Exponentially at a CAGR of 8.0% in the Forecast Period

Global Pulmonary/Respiratory Drug Delivery Market is Rising Exponentially at a CAGR of 7.80%

Global Pulmonary Drug Delivery Market is Rising at a CAGR of 7.0% During the Anticipated Period of 2017 to 2024